TGF-beta isoforms fail to modulate inositol phosphates and cAMP in normal and tumour-derived human oral keratinocytes

A J Collier1, K A Elsegood, W A Yeudall

  • 1Department of Oral and Dental Science, University of Bristol, UK.

Insights

Transforming growth factor-beta (TGF-β) does not regulate inositol phosphate or cyclic adenosine monophosphate (cAMP) in oral keratinocytes. This study found no evidence of these pathways mediating TGF-β signal transduction in normal or tumor cells.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • Transforming growth factor-beta (TGF-β) plays a crucial role in regulating cell growth, differentiation, and apoptosis.
  • Previous studies indicated that human oral keratinocytes express TGF-β receptors and exhibit varied responses to TGF-β isoforms.
  • The specific intracellular signaling pathways mediating TGF-β effects in oral keratinocytes remained unclear.

Purpose of the Study:

  • To investigate the role of inositol phosphate and cyclic adenosine monophosphate (cAMP) signaling pathways in mediating the cellular responses to TGF-β 1, TGF-β 2, and TGF-β 3.
  • To determine if these second messenger systems are involved in TGF-β signal transduction in normal and tumor-derived human oral keratinocytes.

Main Methods:

  • Cultured normal and tumor-derived human oral keratinocytes were treated with TGF-β 1, -β 2, and -β 3.
  • Inositol phosphate levels were measured following stimulation with bradykinin or serum, and in response to TGF-β treatment.
  • Cyclic adenosine monophosphate (cAMP) levels were assessed after treatment with TGF-β isoforms, forskolin (an adenylate cyclase agonist), and dibutyryl cAMP (a cAMP analogue).

Main Results:

  • TGF-β 1, -β 2, and -β 3 failed to modulate inositol phosphate levels in oral keratinocytes.
  • Basal inositol phosphate levels correlated with cell differentiation but not with TGF-β responsiveness.
  • TGF-β isoforms did not affect cAMP levels in tumor-derived cells, even when adenylate cyclase was activated; cAMP analogues did not mimic TGF-β effects.

Conclusions:

  • Transforming growth factor-beta (TGF-β) signal transduction in normal and tumor-derived human oral keratinocytes is not mediated through inositol phosphate or cAMP pathways.
  • These findings exclude common second messenger systems from TGF-β signaling in this cellular context.
  • Further research is needed to elucidate the precise molecular mechanisms underlying TGF-β action in oral keratinocytes.

Related Concept Videos

GTPases and their Regulation02:14

GTPases and their Regulation

Guanine nucleotide-binding proteins (G-proteins), also known as GTPases, are a superfamily of proteins that regulate many cellular processes, such as cell signaling, vesicular transport, and the regulation of cell shape and motility. Mutation or dysfunction of these proteins can lead to disease. There are around 40,000 known G-proteins that can broadly be classified into two groups ‒  small G-proteins consisting of a single domain and large multi-domain G-proteins.
Large G-proteins, also known...
Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...